# Citigroup

Type: Company (C)

Source: GetYourBrief — https://getyourbrief.com/entity/citigroup
Canonical HTML page: https://getyourbrief.com/entity/citigroup

## Timeline

- **2026-08-15**: Wall Street Zen upgrades BKKT and DEI — Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
- **2026-08-15**: Wall Street Zen upgrades BKKT and DEI — Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
- **2026-08-12**: Benchmark cuts BKKT target — Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
- **2026-08-12**: Benchmark cuts BKKT target — Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
- **2026-08-10**: Bakkt reports quarterly results — Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
- **2026-08-10**: Bakkt reports quarterly results — Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
- **2026-08-08**: Wall Street Zen downgrades to Hold — Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.
- **2026-08-07**: Citigroup lifts KVYO target — Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.
- **2026-08-07**: Cantor Fitzgerald raises DEI target — Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
- **2026-08-07**: Cantor Fitzgerald raises DEI target — Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
- **2026-08-06**: KVYO analyst revisions — Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.
- **2026-08-05**: Klaviyo Q2 earnings — Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.
- **2026-08-04**: Douglas Emmett reports earnings — Douglas Emmett reported quarterly EPS of negative $0.02.
- **2026-08-04**: Douglas Emmett reports earnings — Douglas Emmett reported quarterly EPS of negative $0.02.
- **2026-07-30**: OII insider sale — SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.

## Recent coverage (20 stories, network-wide)

### Northwestern Mutual Adds $125.2M in RTX and Cummins Stakes in Q2
2026-08-24 01:15:25 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A Q2 13F filing shows Northwestern Mutual Wealth Management initiated a $106.97M RTX position and an $18.25M Cummins stake. Analysts are raising price targets on both names, reinforcing institutional conviction in industrial cyclicals.
Full story: https://getfinancebrief.com/story/northwestern-mutual-125m-rtx-cummins-13f

### Bakkt's $341M Market Cap Gets Hold Upgrade; Revenue Misses by 54%
2026-08-17 01:01:48 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen's sell-to-hold upgrade for Bakkt comes as the stock trades at $7.66 with a $341.53 million market cap. The move follows a 54% revenue miss and a director's $783,000 insider buy, leaving analysts divided on whether this is a bottom or a value trap.
Full story: https://getfinancebrief.com/story/bakkt-hold-upgrade-wall-street-zen-finance

### Bakkt Upgraded to Hold as BKKT Sits 85% Below Its $49.79 High
2026-08-17 01:01:34 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Crypto platform Bakkt's sell-to-hold upgrade masks a brutal year: shares at $7.66 are down 85% from $49.79. A director's insider buy and an extreme beta of 5.91 frame the risk-reward for Web3 investors watching custody and exchange infrastructure.
Full story: https://getcryptobrief.com/story/bakkt-upgrade-hold-85-percent-below-high

### SaaS Valuation Stress: Klaviyo's 896x P/E Draws Wall Street Zen Hold
2026-08-13 01:19:31 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2

SaaS and cloud operators are watching Klaviyo as a high-multiple vertical SaaS proxy. Wall Street Zen's Buy-to-Hold cut, after Q2 revenue of $370.58 million and EPS in line, shows how quickly a premium valuation can compress when growth doesn't exceed expectations.
Full story: https://getsaasbrief.com/story/saas-klaviyo-wall-street-zen-hold-896-pe

### Klaviyo Hit with Hold at $17.91: 896 P/E Meets $370.6M Q2
2026-08-13 01:19:20 · Sector: marketing · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Marketing and AdTech teams relying on Klaviyo face new investor scrutiny after Wall Street Zen cut the stock to Hold despite Q2 revenue of $370.58 million and in-line EPS of $0.19. The downgrade lands as analyst targets diverge while the company trades at a 895.95 P/E, raising questions about martech spending sustainability.
Full story: https://getmarketingbrief.com/story/klaviyo-wall-street-zen-downgrade-896-pe

### Wall Street Zen Cuts OII and KVYO to Hold: $5B Caps, 14.6 vs 896 P/E
2026-08-13 01:19:06 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
Full story: https://getfinancebrief.com/story/finance-wall-street-zen-downgrade-oii-kvyo

### SoFi Stock Surges 3.7% to $18.70 Despite 5 Analyst Target Cuts – What’s Next?
2026-08-12 13:34:09 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Full story: https://getfinancebrief.com/story/sofi-stock-surges-3-7-percent-analyst-target-cuts

### Wells Fargo Slashes CHKP Target to $130: 13.01 P/E and Consensus Hold Demand Attention
2026-08-12 13:16:01 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Full story: https://getfinancebrief.com/story/chkp-price-target-130-finance-analysis

### Curbline Hits $31.90 High: Retail REIT Signals for PropTech Disruption
2026-08-11 00:43:09 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Curbline Properties' new 52-week high and 460% earnings beat spotlight the vitality of convenience retail real estate, a prime candidate for proptech innovation. Investors should weigh its stretched 101 P/E against low debt and tech-driven growth potential.
Full story: https://getproptechbrief.com/story/curbline-properties-31-90-high-proptech-retail-reit

### SGP Hits $17.56 Low: 156% Upside to $45 Analyst Target
2026-08-10 05:23:16 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts.
Full story: https://getbiobrief.com/story/spyglass-pharma-52-week-low-156-percent-upside-bio

### Hut 8 Call Options Spike 30% to 25.6K as Bitcoin Miner Stock Hits $100
2026-08-05 08:11:43 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Hut 8, a leading Bitcoin miner, saw call options volume explode 30% above average, even as insiders dumped shares and earnings underscored operational leverage. With analyst consensus remaining a Moderate Buy at $121.26 target, the options surge offers a high-stakes crypto-proxy bet for digital asset investors.
Full story: https://getcryptobrief.com/story/hut-8-options-spike-bitcoin-miner

### Zalando Gaps Down 7% on 205-Share Volume: Liquidity Warning?
2026-08-01 18:10:37 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Zalando SE (ZLNDY) shares plunged 7% on Friday with a minuscule 205 shares traded on the OTC market, highlighting the extreme liquidity risks of trading European e-commerce ADRs. Despite analyst upgrades and a $3.52B revenue quarter, the gap-down on such low volume is more a technical artifact than a fundamental signal. Retail investors must weigh the thin order book against the Moderate Buy consensus.
Full story: https://getretailbrief.com/story/zalando-otc-gap-down-liquidity

### Coca-Cola Hands JPMorgan, Citi $1.32B India Bottler IPO as Bank Mandates Soar
2026-08-01 10:28:08 · Sector: finance · Sentiment: Positive · Impact: 6/10 · Sources: 2

Coca-Cola’s selection of JPMorgan and Citi for its 2027 Indian bottler IPO underscores a lucrative equity capital markets wave in India, with $1.32B revenue unit offering a valuable mandate. The deal, also involving Kotak and Morgan Stanley, adds to a string of multinational carve-outs listing in Mumbai.
Full story: https://getfinancebrief.com/story/coca-cola-ipo-jpmorgan-citi-1-32b-india

### Record $104.8B in Q2 IPOs Reopens Exit Path for VC-Backed Startups
2026-07-17 00:44:31 · Sector: startups · Sentiment: Positive · Impact: 7/10 · Sources: 2

After years of waiting, venture-backed companies finally have an open exit window: U.S. IPOs raised a record $104.8 billion in Q2 2026, led by SpaceX. The flood of liquidity promises to unlock stalled VC returns and fuel the next generation of startup funding.
Full story: https://getstartupbrief.com/story/startup-exit-ipo-record-104-billion-q2-2026

### 45% Fee Surge & Record $104.8B IPOs Power Wall Street Revival
2026-07-17 00:44:24 · Sector: finance · Sentiment: Positive · Impact: 7/10 · Sources: 2

The investment banking machine is roaring back: fees at the biggest U.S. lenders vaulted 45% YoY in Q2, propelled by a record $104.8 billion in IPO proceeds. This broad-based resurgence signals a turning point for bank earnings and sets a bullish tone for financial sector stocks.
Full story: https://getfinancebrief.com/story/wall-street-ib-revival-45-percent-fee-surge-record-104-billion-ipos

### JPMorgan's $21.2B Profit Leads Big Bank Q2 Beat: What Investors Need to Know
2026-07-14 15:06:58 · Sector: finance · Sentiment: Neutral · Impact: 8/10 · Sources: 3

Five of America's largest banks shattered earnings expectations for Q2 2026, led by JPMorgan Chase's historic $21.2 billion profit. A confluence of high interest rates, robust trading, and a surge in dealmaking drove the record profits, while stable consumer credit capped loan losses. Investors are now eyeing Morgan Stanley's upcoming report and potential regulatory tailwinds for sustained momentum.
Full story: https://getfinancebrief.com/story/jpmorgan-record-profit-big-bank-q2-2026

### DOJ probes 2 US banks for Iran supreme leader’s network—compliance at risk
2026-07-12 04:02:27 · Sector: legal · Sentiment: Negative · Impact: 6/10 · Sources: 4

The U.S. Department of Justice is investigating JPMorgan Chase and Citigroup for potential sanctions and money-laundering violations tied to Iran’s Supreme Leader. The probe exposes critical compliance gaps and could lead to substantial civil penalties or deferred prosecution agreements.
Full story: https://getlegalbrief.com/story/doj-2-banks-iran-supreme-leader-probe-2026

### Hugo Boss Short Interest Plunges 80.1%: Luxury Retail’s Quiet Bull Signal
2026-07-12 00:23:49 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 1

A dramatic drop in short bets against Hugo Boss signals shifting investor sentiment in luxury retail. With revenue beating estimates and tariff concerns looming, is the luxury sector showing unexpected resilience?
Full story: https://getretailbrief.com/story/hugo-boss-short-interest-retail

### ResMed Faces $270.64 Consensus Target Amid Analyst Divide on Sleep Device Demand
2026-07-10 14:15:23 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
Full story: https://gethealthbrief.com/story/resmed-analyst-target-sleep-apnea-demand

### ResMed Targets Drop to $225 at Wells Fargo; Upside Remains at +23.2%
2026-07-10 14:15:12 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition.
Full story: https://getfinancebrief.com/story/resmed-stock-analyst-target-cuts-wells-fargo

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.